Kreon

Pancreatin, the active ingredient in Kreon, is a pancreatic enzyme preparation presented as an unknown strength enteric‑coated hard gelatin capsule for oral use. It treats exocrine pancreatic insufficiency in patients with cystic fibrosis, chronic pancreatitis, pancreatic cancer and post‑pancreatectomy.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kreon is used to replace deficient pancreatic enzymes in conditions causing exocrine pancreatic insufficiency.

- Exocrine pancreatic insufficiency due to cystic fibrosis: improves digestion and nutrient absorption. - Chronic pancreatitis: aids in the breakdown of dietary fats, proteins and carbohydrates. - Pancreatic cancer: supports digestive function when the pancreas is compromised. - Post‑pancreatectomy: compensates for loss of endogenous pancreatic enzymes.

Kreon may cause a range of adverse reactions, most of which are mild and related to gastrointestinal tolerance.

Common Side Effects: - Abdominal discomfort or cramping. - Flatulence or bloating. - Oily or fatty stools. - Nausea. - Diarrhea. - Constipation.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling. - Severe abdominal pain. - Vomiting of blood. - Unexplained weight loss. - Pancreatitis exacerbation. - Intestinal obstruction.

Before initiating Kreon, consider the following safety measures.

- Dose adjustment: individualize based on clinical response and dietary fat intake. - Medical history: assess for hypersensitivity to porcine‑derived products. - Concurrent disease: monitor growth and nutritional status in cystic fibrosis patients. - Drug monitoring: watch for signs of malabsorption or inadequate enzyme activity. - Pregnancy and lactation: use only if clearly needed after consulting a healthcare professional. - Store at ambient temperature: keep capsules in the original container, protect from moisture and heat.

Kreon can interact with other medications that affect gastric pH or fat digestion.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce enzyme activity. - Proton pump inhibitors: can alter gastric pH, affecting capsule dissolution. - Orlistat: may interfere with fat digestion and enzyme efficacy.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may affect gut flora and enzyme function. - Laxatives containing mineral oil: may bind enzymes and reduce effectiveness. - High‑dose vitamin supplements: may impact absorption of fat‑soluble vitamins.